The Board has determined that the veteran's peripheral neuropathy, including as due to Agent Orange exposure, was not incurred in or aggravated by service and may not be presumed to have been incurred as a result of such service.
The deciding factor: There is no evidence showing acute and subacute peripheral neuropathy within one year following the last date of herbicide exposure, nor any causal relationship between the veteran's exposure to Agent Orange in service and his diagnosed peripheral neuropathy.
- Claimed conditions
- bilateral neuropathy of the lower extremities
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Agent Orange / herbicides
- Rating
- Not verified here — check the original decision
- Decision date
- November 17, 2008
- Citation
- 0839378
This is a plain-language summary generated by AI from a public Board of Veterans’ Appeals decision. It can contain errors — always verify against the original. Search VA.gov for the original decision (opens in a new tab) using citation 0839378.
What this means for you
A final Board denial may be appealed to the U.S. Court of Appeals for Veterans Claims, generally within 120 days of the Board mailing date. A Supplemental Claim with new and relevant evidence is a separate option. Another Higher-Level Review of the Board decision is not available. Check your own notice: this historical decision does not set your deadline.
What you can do next
Use your own notice and decision stage. A remanded issue is not a final court-appealable denial. VA review guidance and CAVC filing instructions (U.S. federal; reviewed October 7, 2026).
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Whole decision: Dismissed
The veteran's appeal for service connection of bilateral neuropathy, chloracne/cutane tarda, and coronary artery disease was dismissed because the veteran requested to withdraw the appeal.
- Whole decision: Remanded (sent back)
The Board has remanded the Veteran's claims of service connection for diabetes type II and bilateral neuropathy of the lower extremities, as both conditions are related to his exposure to PFAS during active duty. The AOJ is instructed to obtain additional evidence confirming the Veteran's exposure to PFAS and to provide a VA examination to determine if his diabetes type II originated during or is etiologically related to service.
- Whole decision: Remanded (sent back)
The Board has remanded the claims for initial review by the AOJ of new evidence, including VA treatment records associated with the Veteran's claim folder since December 2020. The claims will be adjudicated in light of this additional evidence.
- Whole decision: Granted
The Veteran's diffuse large cell lymphoma, diabetes mellitus, type II, and bilateral lower extremity neuropathy are granted as service-connected due to herbicide exposure in Thailand. The balance disability is remanded for further development.
Free starter guide for your own claim
Reading this because you were denied or under-rated? Get the plain-English next steps — your appeal options, the deadline that protects you, and how appeals like yours turn out. One email, no spam.
We will only use this to send the guide. No spam, unsubscribe any time. We never sell your information.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.